The future of cancer epidemiology lies in precision medicine and big data analytics. Advances in genomics and biomarkers will enable more personalized approaches to cancer prevention, early detection, and treatment. Integrating large datasets from various sources will provide more robust insights into cancer epidemiology and help tailor public health interventions.
